TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $270,000 | +21.1% | 100,001 | +3.3% | 0.00% | 0.0% |
| Q1 2018 | $223,000 | -31.8% | 96,803 | -0.9% | 0.00% | -33.3% |
| Q4 2017 | $327,000 | +6.2% | 97,676 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $308,000 | +33.9% | 97,676 | +1.8% | 0.00% | 0.0% |
| Q2 2017 | $230,000 | -38.0% | 95,930 | -2.9% | 0.00% | -33.3% |
| Q1 2017 | $371,000 | -24.3% | 98,837 | -1.2% | 0.00% | -25.0% |
| Q4 2016 | $490,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,889,652 | $18,462,000 | 1.22% |
| WALL STREET ASSOCIATES | 250,000 | $2,442,000 | 0.47% |
| Eventide Asset Management | 403,912 | $3,946,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 485,000 | $4,738,000 | 0.18% |
| J. Goldman & Co LP | 170,000 | $1,661,000 | 0.14% |
| QVT Financial LP | 363,292 | $3,549,000 | 0.12% |
| Kinsight, LLC | 10,053 | $98,000 | 0.07% |
| Welch Group, LLC | 33,769 | $330,000 | 0.06% |
| Visium Asset Management, LP | 436,336 | $4,263,000 | 0.06% |
| Candriam S.C.A. | 135,300 | $1,322,000 | 0.03% |